Earl Martin Douglas

General Counsel, BIOMIMETIC THERAPEUTICS, INC.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Aug 21, 2026Sold 29,697 shares at $2.12 of Allogene Therapeutics, Inc.²
Feb 2, 2026Sold 22,900 shares at $1.76 of Allogene Therapeutics, Inc.³
Feb 3, 2025Sold 6,404 shares at $1.71 of Allogene Therapeutics, Inc.⁴
Jan 24, 2025Granted 144,928 shares of Allogene Therapeutics, Inc.⁵
Aug 21, 2024Shares withheld for tax 28,310 shares at $2.79 of Allogene Therapeutics, Inc.⁶
Jan 25, 2024Granted 41,800 shares of Allogene Therapeutics, Inc.⁷
Aug 14, 2023Granted 326,876 shares of Allogene Therapeutics, Inc.⁸
Aug 14, 2023Granted 108,958 shares of Allogene Therapeutics, Inc.⁸

The numbers on this page point here. Each one links to the record it came from.